XORTX Therapeutics (XRTX) EPS (Basic) (2020 - 2026)
XORTX Therapeutics' (XRTX) quarterly EPS (Basic) came in at -$0.59 in Q1 2026, up 54.13% YoY from -$0.38 in Q1 2025, and up 89.29% on a QoQ basis from -$5.52 in Q4 2025.
XORTX Therapeutics (XRTX) EPS (Basic) (2020 - 2026) Analysis & Trends
XORTX Therapeutics (XRTX) has 7 years of EPS (Basic) data on file, last reported at -$0.59 in Q1 2026.
- Quarterly EPS (Basic) rose 54.13% year-over-year to -$0.59 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$5.5 (down 28.89% YoY) and the FY2025 annual result came in at $2.01, down 52.24% from the prior year.
- EPS (Basic) improved to -$0.59 in Q1 2026, from -$5.52 in the prior quarter.
- In the past five years, EPS (Basic) ranged from a high of $0.25 in Q4 2024 to a low of -$9.96 in Q1 2022.
- A 5-year average of -$2.96 and a median of -$2.86 in 2023 frame the typical range for EPS (Basic).
- Annual changes were most pronounced in 2023 — EPS (Basic) surged 64.74% — and 2025, when it slumped 2310.85%.
- Tracing XRTX's EPS (Basic) over 5 years: stood at -$5.35 in 2022, then surged by 34.86% to -$3.49 in 2023, then jumped by 107.16% to $0.25 in 2024, then slumped by 2310.85% to -$5.52 in 2025, then surged by 89.29% to -$0.59 in 2026.
- The last three EPS (Basic) figures came in at -$0.59 (Q1 2026), -$5.52 (Q4 2025), and -$0.74 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | XORTX Therapeutics | 2.84 Mn | 2.84 Mn | - | -0.59 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -0.59 |
| Dec 31, 2025 | -5.52 |
| Sep 30, 2025 | -0.74 |
| Jun 30, 2025 | -1.17 |
| Mar 31, 2025 | -1.29 |
| Dec 31, 2024 | 0.25 |
| Sep 30, 2024 | -1.51 |
| Jun 30, 2024 | -2.57 |
| Mar 31, 2024 | -2.24 |
| Sep 30, 2023 | -3.49 |
| Jun 30, 2023 | -3.15 |
| Mar 31, 2023 | -3.51 |
| Dec 31, 2022 | -5.35 |
| Sep 30, 2022 | -3.18 |
| Jun 30, 2022 | -3.37 |
| Mar 31, 2022 | -9.96 |
| Dec 31, 2021 | 1.41 |
| Sep 30, 2021 | -1.54 |
| Jun 30, 2021 | -3.38 |
| Mar 31, 2021 | -3.33 |